ÂÜÀòÂÒÂ×

Julia Line currently serves as the Executive Director, Global Commercial Lead for the CNP Franchise at BioMarin Pharmaceutical Inc. since June 2023. Prior to this role, Julia worked at Amgen from January 2018 to May 2023 in various leadership positions including US Commercial Lead for the oncology brand LUMAKRAS, where Julia was instrumental in generating US$200 million in sales during its first year, and Global Marketing Lead for AMG890, focusing on commercialization strategies for a cardiovascular program. Julia's earlier experience includes serving as Chief Marketing Officer at iChild International and holding multiple strategic marketing roles at Eli Lilly and Company, where Julia managed significant diabetes portfolios and led successful product launches. Julia's career began at AstraZeneca as a sales representative, and Julia holds an Executive MBA from AGSM at UNSW Business School and a Bachelor of Science from the University of Melbourne.